GlassScriptPhysician profile
Mariel Miller
NPI 1245707629
$1,763.12
in general payments reported to CMS, 2019-2025
21 companies · $587 in 2025
The $587 reported for 2025 was more than what 79% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $68.28 · 2023: $470 · 2024: $637 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,694.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $384.01 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $363.02 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $208.84 | 2022-2025 | Camzyos, Eliquis |
| Pfizer INC. | $195.45 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $107.94 | 2023-2024 | |
| Abbott Laboratories | $74.07 | 2023 | Mitraclip, Gallant |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.24 | 2023-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $44.43 | 2022-2025 | Verquvo |
| Amgen INC. | $42.15 | 2023-2024 | Repatha |
| Alnylam Pharmaceuticals INC. | $39.66 | 2022-2025 | Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $35.38 | 2025 | |
| Scpharmaceuticals INC. | $31.77 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $27.89 | 2023 | Lokelma |
| Sanofi-Aventis U.S. LLC | $26.38 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $23.86 | 2024 | Evkeeza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $19.97 | 2023 | Xarelto |
| Hologic Sales and Service, LLC | $19.44 | 2024 | Aptima |
| Medtronic, INC. | $18.94 | 2023 | Venaseal |
| Kiniksa Pharmaceuticals International, Plc | $18.25 | 2024 | Arcalyst |
| Lilly USA, LLC | $16.21 | 2024 | Zepbound |
| Bard Peripheral Vascular, INC. | $14.22 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariel Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.